Adherence to medication is crucial in clinical trials because it directly affects the integrity and validity of the study results. Clinical trials are designed to evaluate the safety and efficacy of new drugs, treatments, or interventions in a controlled and systematic manner. Therefore, study participants must take their medication as prescribed to ensure the trial results are accurate and reliable. Poor medication adherence can lead to several issues in clinical trials. For example, it may result in incomplete or inconsistent data, which can compromise the study’s statistical power and reduce the ability to detect significant differences between the treatment groups. Additionally, non-adherence can lead to biased results, as patients who do not take their medication as prescribed may have different outcomes than those who do, even if they are in the same treatment group. To minimize the impact of poor adherence, clinical trial protocols typically include measures to promote and monitor medication adherence, such as providing education and counseling. However, while education and counseling can certainly promote better adherence, in clinical trials with many participants, getting to the participants that require additional support can be challenging. That’s where AARDEX Group’s solutions come into play. Our medication adherence solution continuously monitors participant medication events to guide researchers to the participants that need support. Inherent stratification lists provide a ranked view of participants prioritized by the participants with problematic behaviors (missed days, drug holidays, overdoses, etc.) By ensuring high levels of medication adherence, clinical trials can produce robust and accurate results, which are essential for making informed decisions about the safety and effectiveness of new treatments.